TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Drug Interaction Details
01. General Information
Pair Name Berbamine, Aspirin
Phytochemical Name Berbamine (PubChem CID: 275182 )
Anticancer drug Name Aspirin (PubChem CID: 2244 )
Structure of
Phytochemical
2D-img
Download
2D MOL 3D MOL
Structure of
Anticancer Drug
2D-img
Download
2D MOL 3D MOL
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 28
Pair Name Berbamine, Aspirin
Disease Info [ICD-11: 2C12] Hepatocellular carcinoma Investigative
Gene Regulation Down-regulation Phosphorylation ATF1 hsa466
Down-regulation Expression CCND1 hsa595
Down-regulation Expression CIP2A hsa57650
Down-regulation Phosphorylation CREB1 hsa1385
In Vitro Model Hep-G2 Hepatoblastoma Homo sapiens (Human) CVCL_0027
Hep 3B2.1-7 Childhood hepatocellular carcinoma Homo sapiens (Human) CVCL_0326
In Vivo Model HepG2 cells (4×10⁶ in 125 μL PBS) were subcutaneously injected into 5-week-old BALB/c nude mice.
Result These data demonstrate that the regulation of cAMP-PKA-CREB/ATF1 signaling represents a noncanonical function of CPS1. Targeting the PKA-CREB/ATF1 axis may be a strategy to improve the therapeutic effects of aspirin on HCC.
03. Reference
No. Title Href
1 Blockade of AMPK-Mediated cAMP-PKA-CREB/ATF1 Signaling Synergizes with Aspirin to Inhibit Hepatocellular Carcinoma. Cancers (Basel). 2021 Apr 6;13(7):1738. doi: 10.3390/cancers13071738. Click
It has been 47606 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP